Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Myocet liposomal (previously Myocet)

Myocet liposomal 50 mg powder, dispersion and solvent for concentrate for dispersion for infusion. · Abschnitt 4.8 · PDF-Seite 6–7

HOS-091147 · Präparat HOS-084209

6  All grades Grades ≥ 3 Leucopenia Very common Very common Lymphopenia Common Common Pancytopenia Common Uncommon Neutropenic sepsis Uncommon Uncommon Purpura Uncommon Uncommon Metabolism and nutrition disorders Anorexia Very common Very common Dehydration Common Very common Hypokalaemia Common Uncommon Hyperglycaemia Uncommon Uncommon Psychiatric disorders Agitation Uncommon Not known Nervous system disorders Insomnia Common Uncommon Abnormal gait Uncommon Uncommon Dysphonia Uncommon Not known Somnolence Uncommon Not known Cardiac disorders Arrhythmia Common Uncommon Cardiomyopathy Common Common Congestive cardiac failure Common Common Pericardial effusion Uncommon Uncommon Vascular disorders Hot flushes Common Uncommon Hypotension Uncommon Uncommon Respiratory, thoracic and mediastinal disorders Chest pain Common Uncommon Dyspnoea Common Uncommon Epistaxis Common Uncommon Haemoptysis Uncommon Not known Pharyngitis Uncommon Not known Pleural effusion Uncommon Uncommon Pneumonitis Uncommon Uncommon Gastrointestinal disorders Nausea/vomiting Very common Very common Stomatitis/mucositis Very common Common Diarrhoea Very common Common Constipation Common Uncommon Oesophagitis Common Uncommon Gastric ulcer Uncommon Uncommon Hepatobiliary disorders Increased hepatic transaminases Common Uncommon Increased alkaline phosphatase Uncommon Uncommon Jaundice Uncommon Uncommon Increased serum bilirubin Uncommon Not known

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.